The Role of rituximab for newly diagnosed, refractory or relapsed aggressive B-cell lymphoma in adult patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Role of rituximab for newly diagnosed, refractory or relapsed aggressive B-cell lymphoma in adult patients

Published:2016-12-08 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Fitzmaurice Christina¹,Zinke Richard²,Heraly Bradley³,Kahl Brad⁴

Affiliation:

1. University of Washington/Fred Hutchinson Cancer Research Center; Hematology-Oncology; 1100 Fairview Ave N - D5-100 PO Box 19024 Seattle Washington State USA 98109-1024

2. University of Rochester Medical Center; James P. Wilmot Cancer Institute; 601 Elmwood Avenue, Box 704 Rochester, USA NY 14642

3. Devision of Hematology, Oncology and Transplantation; 420 Delaware, SE MMC 480 Minneapolis MN USA 55455

4. University of Wisconsin Hospital and Clinics; Department of Internal Medicine; 600 Highland Ave Madison WI USA 53705

Publisher

Wiley

Subject

Pharmacology (medical)

Reference110 articles.

1. Calculating the number needed to treat for trials where the outcome is time to an event;Altman;British Medical Journal,1999

2. The Lugano International Conferences on Malignant Lymphoma, 1981–1993

3. Subject index Volume 5, supplement 2

4. Esophageal Cancer: Surgery of squamous cell carcinoma of the esophagus

5. Introduction

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP